Search Results - "Kohli, Harbir"

Refine Results
  1. 1
  2. 2
  3. 3

    Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis by Rathi, Manish, Goyal, Ajay, Jaryal, Ajay, Sharma, Aman, Gupta, Pramod K, Ramachandran, Raja, Kumar, Vivek, Kohli, Harbir S, Sakhuja, Vinay, Jha, Vivekanand, Gupta, Krishan L

    Published in Kidney international (01-01-2016)
    “…No previous study has compared mycophenolate mofetil (MMF) with low-dose cyclophosphamide (CYC) in the treatment of lupus nephritis (LN). To do so, we…”
    Get more information
    Journal Article
  4. 4

    Tunneled femoral vein catheterization for long-term hemodialysis - Experience from a tertiary care center by Sethi, Jasmine, Gaur, Mragank, Rathi, Manish, Kohli, Harbir

    Published in Indian journal of nephrology (01-07-2022)
    “…Introduction: Tunneled femoral vein hemodialysis catheters are used when all other options for permanent vascular access or jugular central vein catheter are…”
    Get full text
    Journal Article
  5. 5

    Glomerulonephritis with crescents in polyomavirus nephropathy by Sekar, Aravind, Nada, Ritambhra, Kohli, Harbir, Sharma, Ashish

    Published in Indian journal of nephrology (01-11-2022)
    “…Polyomavirus nephropathy (PVN) is a known complication of renal transplantation due to the reactivation of latent BK virus (BKV) infection. Viral replication…”
    Get full text
    Journal Article
  6. 6

    A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy by JHA, Vivekanand, GANGULI, Anirban, SAHA, Tarun K, KOHLI, Harbir S, SUD, Kamal, GUPTA, Krishan L, JOSHI, Kusum, SAKHUJA, Vinay

    “…Idiopathic membranous nephropathy (IMN) is the most common cause of nephrotic syndrome in adults. Universal consensus regarding the need for and the modality…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Augmented mannose‐binding lectin levels in primary membranous nephropathy: A pilot study by Pal, Deeksha, Inamdar, Neeraj, Kaur, Prabhjot, Singhal, Manphool, Lal, Anupam, Gorsi, Ujjwal, Nada, Ritambhra, Kohli, Harbir S., Kumar, Vinod, Ramachandran, Raja

    Published in Nephrology (Carlton, Vic.) (01-09-2024)
    “…There is evidence to suggest that M‐type phospholipase A2 (PLA2R) antibodies activate the mannose‐binding lectin (MBL) cascade, resulting in glomerular damage…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Fungal infection in post-renal transplant patient: Single-center experience by Gupta, Krishan, Bagai, Sahil, Ramachandran, Raja, Kumar, Vivek, Rathi, Manish, Kohli, Harbir, Sharma, Ashish, Chakrabarti, Arunaloke

    Published in Indian journal of pathology & microbiology (01-10-2020)
    “…Introduction: Fungi are ubiquitous organisms and significantly alter the post-transplant course. They are a major cause of morbidity and mortality and more so…”
    Get full text
    Journal Article
  12. 12

    ANCA-Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature by Shukla, Shubham, Sekar, Aravind, Naik, Sachin, Rathi, Manish, Sharma, Aman, Nada, Ritambhra, Kohli, Harbir S, Ramachandran, Raja

    Published in Indian journal of nephrology (01-03-2024)
    “…Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) rarely coexist with systemic thrombotic microangiopathy (TMA).The TMA can be in the form…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Persistent CD‐19 depletion by rituximab is cost‐effective in maintaining remission in calcineurin‐inhibitor dependent podocytopathy by Ramachandran, Raja, Bharati, Joyita, Rao, Indu, Kashif, Ahmed W, Nada, Ritambhra, Minz, Ranjana, Gupta, Krishan L, Kohli, Harbir S

    Published in Nephrology (Carlton, Vic.) (01-12-2019)
    “…ABSTRACT Aim A significant proportion of patients with minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are either steroid dependent…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Rituximab in maintaining remission in adults with podocytopathy by Ramachandran, Raja, Bharati, Joyita, Nada, Ritambhra, Minz, Ranjana, Kohli, Harbir S.

    Published in Nephrology (Carlton, Vic.) (01-08-2020)
    “…Rituximab is currently used after the conventional agents have failed in the management of steroid‐dependent (SD)/ steroid‐resistant (SR) podocytopathies and…”
    Get full text
    Journal Article
  19. 19
  20. 20